Table 2. Clinical data in control and patient groupsa

CharacteristicPatient Group (mean ± SD)Control Group (mean ± SD)P Value
a n = 136 and n = 4 for patient and control groups, respectively.
Age (yr)41 ± 2048.6 ± 10.8< 0.001
Urea (mg/dl)110.3 ± 99.132.4 ± 11.3< 0.001
Serum creatinine (mg/dl)4.1 ± 4.40.9 ± 0.5< 0.001
MAP (mmHg)108.6 ± 18.295.1 ± 5.8< 0.001
24-h proteinuria (g/24 h)3.1 ± 2.80.20.1< 0.001
Glomerulosclerosis (%)4.5 ± 3.40.4 ± 0.7< 0.001
Interstitial fibrosis (%)21.2 ± 10.93.8 ± 1.9< 0.001
Mesangial cellularity (score 0 to 3)1.9 ± 1.01.1 ± 0.8< 0.001
Tubular atrophy (score 0 to 3)1.32 ± 1.00.00 ± 0.00< 0.001
Interstitial Inflammation (score 0 to 3)1.03 ± 0.870.01 ± 0.01< 0.001